@article{201ee23bb03546e8a9510110e7185340,
title = "Letter to the Editor Regarding “Gabapentin has Longer-Term Efficacy for the Treatment of Chronic Pelvic Pain in Women: A Systematic Review and Pilot Meta-analysis”",
author = "Katy Vincent and Horne, \{Andrew W.\} and Daniels, \{Jane P.\}",
note = "Funding Information: Katy Vincent has received research funding from Bayer Healthcare and Honoraria and travel expenses for consultancy and lectures from Bayer Healthcare, AbbVie, Grunenthal GmBH, and Eli Lilly. AWH reports grant funding from the MRC, NIHR, CSO, Wellbeing of Women, Roche Diagnostics, Astra Zeneca, Ferring, Charles Wolfson Charitable Trust, Standard Life, Consultancy fees from Roche Diagnostics, AbbVie, Nordic Pharma and Ferring. In addition, Andrew W. Horne has a patent pending for a serum biomarker for endometriosis. Jane P. Daniels reports no disclosures. ",
year = "2022",
month = jan,
day = "19",
doi = "10.1007/s40122-021-00351-z",
language = "English",
journal = "Pain and Therapy",
issn = "2193-8237",
publisher = "Springer",
}